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Abstract
Meroterpenoids are a class of fungal natural products that are produced from polyketide and
terpenoid precursors. An understanding of meroterpenoid biosynthesis at the genetic level should
facilitate engineering of second-generation molecules and increasing production of first-generation
compounds. The filamentous fungus Aspergillus nidulans has previously been found to produce
two meroterpenoids, austinol and dehydroaustinol. Using targeted deletions that we created, we
have determined that, surprisingly, two separate gene clusters are required for meroterpenoid
biosynthesis. One is a cluster of four genes including a polyketide synthase gene, ausA. The
second is a cluster of ten additional genes including a prenyltransferase gene, ausN, located on a
separate chromosome. Chemical analysis of mutant extracts enabled us to isolate 3,5-
dimethylorsellinic acid and ten additional meroterpenoids that are either intermediates or shunt
products from the biosynthetic pathway. Six of them were identified as novel meroterpenoids in
this study. Our data, in aggregate, allow us to propose a complete biosynthetic pathway for the A.
nidulans meroterpenoids.
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Fungal species are known to produce a variety of structurally complex secondary
metabolites many of which have important relevance to human health.1 Members of the
genus Aspergillus can combine polyketide and terpenoid precursors to produce structurally
complex secondary metabolites called meroterpenoids.2 Examples of known meroterpenoids
include terretonin and territrem produced by A. terreus,3,4 pyripyropene A produced by
certain strains of A. fumigatus,5,6 austin produced by A. ustus7 and austinol (1) and
dehydroaustinol (2) produced by A. nidulans (Fig. 1).8,9 Territrem is a potent irreversible
inhibitor of acetylcholinesterase (AChE) and is a candidate for drug development for
treating Alzheimer’s disease.4 Pyripyropene is a potent selective inhibitor of acyl-CoA
cholesterol acyltransferase (ACAT), an enzyme that catalyzes intracellular esterification of
cholesterol and is being developed for treating and preventing atherosclerosis.5,6
A series of labeling studies in the eighties provided a framework for the biosynthetic
mechanism of meroterpenoids.10,11,12 Recently the biosynthetic gene cluster of
pyripyropene was identified in A. fumigatus and verified using a heterologous fungal
expression approach.13 The pyripyropene gene cluster encodes one nonreducing polyketide
synthase (NR-PKS), one prenyltransferase, one CoA ligase, two cytochrome P450s, one
FAD-dependent monooxygenase, one terpene cyclase and two acetyltransferases.
In this study we attempted to locate the biosynthesis genes for austinol (1) and
dehydroaustinol (2) in A. nidulans by searching the A. nidulans genome for regions where a
NR-PKS gene and a prenyltransferase gene are in proximity. Interestingly no
prenyltransferase genes were located near NR-PKS genes. This suggested to us that the
genes responsible for austinol (1) and dehydroaustinol (2) biosynthesis in A. nidulans might
be separated in the genome. Although secondary metabolite biosynthesis genes are generally
clustered in fungal genomes,1 we recently showed that the genes that encode the prenyl
xanthone biosynthesis pathway in A. nidulans are located in three separate regions of the
genome.14
We identified, using a set of deletions of all non-reducing PKS genes, the NR-PKS
responsible for the biosynthesis of the meroterpenoids in A. nidulans. This NR-PKS has
been independently identified by Nielsen et al. and designated ausA.15 Next we selected two
candidate prenyltransferase genes located elsewhere in the genome for deletion and from
metabolome analysis of mutant extracts, we found that one was involved in meroterpenoid
synthesis. To identify additional genes involved in the pathway we targeted the genes
surrounding the NR-PKS gene and the prenyltransferase gene for deletion. The gene
deletion experiments allowed us to identify twelve additional genes involved in
meroterpenoid biosynthesis, that are located in two gene clusters, one containing the NR-
PKS and the other containing the prenyltransferase. Large-scale cultures of the deletion
strains enabled us to isolate several stable intermediates (Fig. 2) including six novel
compounds allowing us to propose a biosynthesis pathway for austinol (1) and
dehydroaustinol (2) biosynthesis.
RESULTS
Identification of the polyketide synthase responsible for austinol (1) and dehydroaustinol
(2) biosynthesis
When cultivated on solid yeast agar glucose (YAG) medium A. nidulans produces two
meroterpenoids, austinol (1) and dehydroaustinol (2) (Fig. 1).8,9 The structural similarity of
these two compounds suggests that they may have the same biosynthetic origin. For this
study we used an A. nidulans strain containing the nkuAΔ and stcJΔ mutations. The nkuAΔ
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deletion allows high homologous recombination rates and facilitates gene targeting. stcJΔ
prevents production of the major A. nidulans polyketide sterigmatocystin. The rationale for
the use of an stcJΔ strain is that the elimination of sterigmatocystin frees up the common
polyketide precursor malonyl-CoA and also facilitates the detection and isolation of other
metabolites. Early studies using labeled precursors showed that austin, which is very similar
to austinol (1), is formed by the C-alkylation of 3,5-dimethylorsellinic acid, an aromatic
polyketide, with farnesyl pyrophosphate.10 Because fungal secondary metabolite
biosynthesis genes are usually clustered, we first looked for a PKS near a prenyltransferase
in the A. nidulans genome in an effort to identify the meroterpenoid gene cluster.
Surprisingly, we found no PKS near a prenyltransferase on any chromosome, leading us to
conclude that the PKS and prenyltransferase genes required for austinol (1) and
dehydroaustinol (2) biosynthesis must be separated in the genome. We consequently used a
genome-wide gene targeting approach to locate the austinol (1) and dehydroaustinol (2)
biosynthesis genes.
To locate the PKS responsible for austinol (1) and dehydroaustinol (2) we first determined,
based on a comparison to other previously characterized fungal aromatic polyketides, that
the aromatic structure of the predicted precursor 3,5-dimethylorsellinic acid (3) (Fig. 2)
would likely require a non-reducing PKS (NR-PKS). Previously, we created NR-PKS knock
out libraries in two different genetic backgrounds in A. nidulans to elucidate products of
these NR-PKSs. Using these libraries we identified the NR-PKS involved in the biosynthesis
of asperthecin,9 emodin,16 the prenylated xanthones,14 orsellinic acid and F-9775A/B.16,17
Separately we demonstrated that the NR-PKS gene AN1034.4 is involved in asperfuranone
biosynthesis inducing a nearby transcription factor located within the gene cluster.18 The
products of the remaining six NR-PKS (encoded by AN0523.4, AN2032.4, AN3230.4,
AN3386.4, AN6448.4, AN7071.4) were unknown. Strains carrying these deletions were
cultivated under austinol (1) and dehydroaustinol (2) producing conditions and metabolites
were analyzed by liquid chromatography-diode array-mass spectrometry (LC-DAD-MS).
We found that all these strains continued to produce the two meroterpenoids (data not
shown) and, thus, that none of these NR-PKS is involved in meroterpenoid production.
We reexamined the A. nidulans genome using the gene annotations of the Central
Aspergillus Data Repository (CADRE) (http:www.cadre-genomes.org.uk) and the
Aspergillus genome database (http://www.aspgd.org) and located AN8383.4, encoding a
putative NR-PKS gene for which we had not created a deletant mutant in our previous
studies due to an error in the initial annotation. Expression of AN8383.4 in another project
revealed that it is responsible for the synthesis of 3,5-dimethylorsellinic acid, a likely
precursor of the meroterpenoids (M. Ahuja et al., submitted). We consequently created
deletion strains for AN8383.4 (AN8383.4Δ) using the gene-targeting procedures we have
recently developed for A. nidulans involving a nkuAΔ strain and fusion PCR.19,20
Diagnostic PCR using three different primer sets confirmed that AN8383.4 was deleted
correctly and we have used the same technique to verify the deletions in all strains used in
this study (Fig.S3 and S4). The AN8383.4Δ strain was cultivated under austinol/
dehydroaustinol producing conditions and LC-DAD-MS analysis showed that it failed to
produce the two meroterpenoids (Fig. 3). These data allow us to identify AN8383.4 as the
gene responsible for the biosynthesis of austinol (1) and dehydroaustinol (2).
AN8383.4 is located on chromosome V at bp 307999-315732. AN8383.4 is predicted to
encode a 2476 amino acid NR-PKS which contains starter unit ACP transacylase (SAT), β-
ketoacyl synthase (KS), acyltransferase (AT), product template (PT), acyl carrier protein
(ACP), C-methyltransferase (C-MeT) and thiolesterase (TE) domains. During the course of
this work, Nielson et al. reported the independent discovery that AN8383.4 is involved in
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austinol/dehydroaustinol synthesis and designated it ausA.15 For consistency, we will also
use this designation.
Identification of the prenyltransferase involved in austinol and dehydroaustinol
biosynthesis
The prenylation of 3,5-dimethylorsellinic acid produced by the NR-PKS AusA (the protein
product of the ausA gene) must be catalyzed by a prenyltransferase. Since none of the genes
located near ausA have homology to any known prenyltransferase, we looked to other parts
of the genome to locate the necessary prenyltransferase. We performed a BLAST search of
the A. nidulans genome using the amino acid sequence of UbiA as a query to search for its
homologs. The UbiA enzyme is involved in the biosynthesis of prenylated quinones such as
ubiquinone in E. coli.21 This enzyme catalyzes the transfer of all-trans prenyl moieties to the
acceptor molecule 4-hydroxybenzoate (4HB). This enzyme was selected because it catalyzes
C-C bond formation between an aromatic substrate and an isoprenoid diphosphate.
The top two candidate genes in the BLAST search were AN9259.4 and AN8142.4.
Deletions were created and verified for each. Cultivation and analysis of the deletant strain
by LC-DAD-MS showed that the AN8142.4 deletant (AN8142.4Δ) continued to synthesize
austinol (1) and dehydroaustinol (2) while AN9259.4Δ failed to produce the two
meroterpenoids (Fig. 3). We deduced therefore that AN9259.4 is required for austinol (1)
and dehydroaustinol (2) biosynthesis and we designate it ausN.
From an ausNΔ strain we isolated, and characterized by NMR and mass spectrometry, 3,5-
dimethylorsellinic acid (3) the polyketide precursor of austin biosynthesis predicted from
earlier labeling studies.10 We also isolated this precursor in our AN8383.4 overexpression
studies (M. Ahuja et al., submitted) indicating that ausA makes 3 which is subsequently
modified by the product of ausN. Both the genetic data and the isolation of 3,5-
dimethylorsellinic acid (3), thus, demonstrate that ausN is the prenyltransferase involved in
biosynthesis of the two meroterpenoids. It is located on chromosome VIII while ausA is on
chromosome V.
Targeted gene deletions reveal additional genes required for meroterpenoid biosynthesis
Early labeling studies showed that a series of oxidation steps are necessary for the
biosynthesis of the austinol related molecule austin.12 Since the genes involved in the
biosynthesis of particular secondary metabolites are usually clustered in fungi,22 we wished
to delete genes surrounding ausA and ausN to identify other genes required for austinol and
dehydroaustinol biosynthesis. A problem with respect to the ausA region was that there was
a gap near ausA in the genome (i.e. the contiguous sequence containing ausA could not be
connected to the adjacent contiguous sequence apparently because sequences were missing).
To fill in this gap we amplified A. nidulans genomic DNA using primers flanking the gap.
We sequenced the resulting fragment and found that the apparent gap was actually due to the
insertion of an incorrect sequence. Once this sequence was eliminated the sequences on the
two sides of the “gap” overlapped and matched perfectly and the gap was, thus, eliminated.
We found that AN8381.4 extended across the previously incorrectly annotated gap. We
communicated this information to CADRE and the gap has now been corrected in the
CADRE and ASPGD databases.
We deleted twelve genes surrounding ausA (AN8376.4, AN8377.4, AN8378.4, AN8379.4,
AN8380.4, AN8381.4, AN8382.4, AN8384.4, AN8385.4, AN11077.4, AN11085.4, and
AN8387.4) (Fig. 4A). Three putative deletants for each gene were verified by diagnostic
PCR using three different primer sets. For each gene at least two of the three deletants
proved correct (Fig. S4). At least two strains per gene were cultivated under austinol/
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dehydroaustinol producing conditions and the culture extracts screened by LC/MS.
Deletions of AN8379.4, AN8381.4, AN8384.4 fully eliminated the production of both
meroterpenoids (Fig. 4B) and we designate these genes ausB, ausC, and ausD respectively.
We were able to detect by LC/MS a new UV active compound 4 from the ausBΔ strains. An
ausBΔ strain was grown at a large scale and compound 4 was isolated by flash
chromatography and preparative scale HPLC. Using both 1D and 2D NMR spectroscopy we
determined the structure of compound 4 (NMR data shown in supporting information),
which we named protoaustinoid A (4). Protoaustinoid A (4) has a tetracyclic structure with a
1,3-diketone functional group. A similar compound was proposed earlier as a key early
intermediate in austin biosynthesis.12 Protoaustinoid A contains a methyl ester connected to
carbon 8' instead of the carboxylic function group in the previously proposed structure.12
From both AN8381.4Δ and AN8384.4Δ strains we were unable to obtain sufficient amounts
of stable intermediates to elucidate the roles of the two genes in the biosynthetic pathway.
We believe we have established one border of the gene cluster surrounding the PKS using
the AN8376.4Δ, AN8377.4Δ, and AN8378.4Δ strains since these strains continue to
produce the two meroterpenoids. The other border is established by the AN8385.4Δ,
AN11077.4Δ, AN11085.4Δ, and AN8387.4Δ strains since these strains also continue to
produce the two meroterpenoids. Our deletion data have, thus, allowed us to identify three
genes surrounding the PKS gene ausA that are involved in the pathway.
The structural complexity of austinol/dehydroaustinol led us to believe that additional genes
are necessary for their biosynthesis. We hypothesized that they are located adjacent to the
prenyltransferase gene ausN and that deletion of genes in this region would reveal the
remaining genes required for meroterpenoid biosynthesis. Initially we targeted nine genes
surrounding the prenyltransferase gene ausN. The nine genes were AN11205.4, AN9256.4,
AN11647.4, AN9257.4, AN11217.4 AN11206.4, AN11648.4, AN9260.4, and AN9261.4
(Fig. 5A). Three putative deletants for each gene were tested by diagnostic PCR using three
different primer sets. At least two correct deletants per gene were cultivated under
meroterpenoid producing conditions and screened by reverse-phase LC/MS. Metabolite
profiles of AN11648.4, AN9260.4, and AN9261.4 deletants showed that they are not
involved in austinol/dehydroaustinol biosynthesis and they define one of the boundaries for
this cluster (Fig. 5 and Fig. S2). Because LC/MS analysis showed that AN11205.4 (ausK) is
involved in the biosynthesis of the two meroterpenoids, we created additional gene deletants
beyond AN11205.4 to look for the left boundary. We deleted twelve additional genes
AN9244.4, AN9245.4, AN9246.4, AN9247.4, AN9248.4, AN9249.4, AN9250.4,
AN9251.4, AN9252.4, AN9253.4, AN9254.4, AN11214.4, a total of 22 genes for this
cluster, including ausN. We verified at least two deletants for each gene and used them for
LC/MS analysis. The results show that AN9246.4 (ausE), AN9247.4 (ausF), AN9248.4
(ausG), AN9249.4 (ausH), AN9253.4 (ausI), AN11214.4 (ausJ), AN11025.4 (ausK),
AN9257.4 (ausL) and AN11206.4 (ausM), are involved in the biosynthesis pathway since
they fully eliminated the production of both meroterpenoids, except that deletion of
AN9247.4 (ausF) permitted minor production of austinol/dehydroaustinol (Fig. 5B). The
low production of austinol/dehydroasutinol by AN9247.4 deletion strains was confirmed by
MS/MS (data not shown). This suggests that AN9247.4 might be involved in a late step of
the biosynthesis pathway or, more likely, may have a regulatory function. Our gene deletion
data in total allow us to deduce that AN9246.4 and AN9259.4 define the borders of the gene
cluster surrounding ausN.
Several of our deletion strains produced sufficient amounts of chemically stable metabolites
to allow us to isolate them and determine their structures using 1D and 2D NMR
spectroscopy (NMR data for all the intermediates are shown in supporting information.).
Compounds 5 – 13 isolated from large-scale cultures of the deletant strains are all
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meroterpenoids that are either proposed intermediates or shunt products in the austinol (1)
and dehydroaustinol (2) biosynthesis pathways. Preaustinoid A3 (5), isoaustinone (7),
austionolide (9) and austinoneol A (11) have been previously isolated and identified from
Penicillium sp and have been proposed to be intermediates in austin biosynthesis.23 Our
NMR analysis of these four compounds are in agreement with published NMR data of these
compounds. The remaining chemicals that accumulated in the deletion strains were
structurally characterized and found to be novel materials. We designate them preaustinoid
A4 (6), 11β-hydroxyisoaustinone (8), preaustinoid A5 (10), (5'R)-isoaustinone (12), and
neoaustinone (13). X-ray crystallographic analysis confirmed the absolute configuration of
(5'R) – isoaustinone (12) (Fig. S5).
DISCUSSION
Using a series of targeted gene deletions, we have identified the genes encoding the
biosynthesis pathway for the meroterpenoids austinol (1) and dehydroaustinol (2) in A.
nidulans (Fig. 6). The pathway involves at least 14 genes in two separate gene clusters.
Three genes are clustered around the polyketide synthase gene AN8383.4 (ausA) located on
chromosome V and nine genes are clustered around the prenyltransferase gene AN9259.4
(ausN) located on chromosome VIII. For ease of reference we will call these two clusters,
cluster A and cluster B respectively. Our findings illustrate the power of combining
genomics, efficient gene targeting and natural products chemistry. Without combining these
approaches, it would not have been possible to identify the genes involved in austinol and
dehydroaustinol biosynthesis nor to obtain adequate data to propose a biosynthetic pathway
for these compounds.
In our proposed pathway, the first gene, ausA, encodes a polyketide synthase for 3,5-
dimethylorsellinic acid (3) synthesis. AusA contains the SAT, KS, AT, PT, ACP, CMet, and
TE domains, and the lack of ER, DH, and KR domains indicates that it is an NR-PKS.24
This NR-PKS may utilize one acetyl-CoA, three malonyl-CoA, and two SAM (S-adenosyl
methionine) to produce compound 3.
In the next step, C-alkylation of compound 3, an aromatic polyketide, by farnesyl
pyrophosphate is catalyzed by an aromatic prenyltransferase AusN. We were able to isolate
3,5-dimethylorsellinic acid (but not austinol, dehydroaustinol nor any other intermediate)
from the ausN deletion strain, which provides solid evidence that ausN encodes the
prenyltransferase in the pathway and that the prenylation step occurs very early in the
pathway, before other intermediates are synthesized. BLAST analysis revealed that AusN
has 49% protein sequence similarity to LePGT-1 an aromatic prenyltransferase (Table 1).
The enzymatic activity of LePGT-1 was examined by Yazaki et al.25 They showed that
LePGT-1, which is a homologous to UbiA, makes 4-hydroxybenzoate an intermediate in
shikonin biosynthesis in Lithospermum erythrorhizon. Analysis of the predicted protein
sequence of AusN led to the identification of an aspartate-rich motif (88-NDLVDVDID-96)
similar to LePGT-1. This NDXXDXXXD motif, which binds the prenyl diphosphate via a
Mg2+ ion, is highly conserved among all prenyltransferases involved in lipoquinone
biosynthesis.26 Unlike prenyltransferase enzymes such as protein prenyltransferases or
fungal indole prenyltransferases, which are water soluble, lipoquinone prenyltransferases are
membrane bound.26 In addition, AusN was predicted to have nine transmembrane helices by
MEMPACK [on the PsiPred server (http://bioinf.cs.ucl.ac.uk/psipred/)]. Therefore, AusN
could be a membrane bound aromatic prenyltransferase that catalyzes the transfer of a
prenyl moiety to an aromatic acceptor molecule.
The next steps include the epoxidation of the prenylated polyketide intermediate possibly by
the epoxidase encoded by the gene ausM followed by cyclization, catalyzed by a terpene
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cyclase to form the tetracyclic intermediate. We were unable to isolate analyzable amounts
of the proposed prenylated polyketide 15 and the proposed epoxidated intermediate 16
presumably because these two intermediates are not sufficiently stable in our purification
scheme (Fig. 6).
Although no intermediate could be isolated from ausM and ausL deletant strains, we can
propose functions for them based on homology. BLAST searches with AusM showed that it
has 65% similarity to an epoxidase, PaxM, involved in paxilline biosynthesis.27 It also has
58% similarity to another epoxidase encoded by pyr5 which catalyzes the epoxidation of the
terpenoid moiety of farnesyl 4-hydroxy-6-(3-pyridinyl)-2H-pyran-2-one (HPPO) in
pyripyropene A biosynthesis.13 Based on the epoxidation functions of its homologs, we
propose that AusM catalyzes the epoxidation of the terminal alkene of terpenoid moiety of
15 to form 16.
We propose that the terpene cyclization step is catalyzed by AusL. This enzyme has 55%
similarity to the enzyme encoded by pyr4, which is a terpene cyclase involved in
pyripyropene A biosynthesis in Aspergillus fumigatus.13 Both AusL and Pyr4 are annotated
as “integral membrane protein” by the Broad Institute website
(http://www.broadinstitute.org/) and their sizes are smaller than any other terpene cyclases
identified so far. This smaller size of pyr4 led Itoh et al. to describe it as a novel terpene
cyclase.13 When we examined AusL, we identified a conserved residue (E62) in its
sequence that, in other terpene cyclases, is proposed to be involved in the protonation of the
epoxide ring that may trigger the following polyene cyclization step.28
Next, the lactone system in the ring A of 4 is formed via a Baeyer-Villiger oxidation by
AusB. We were able to isolate large quantities of compound 4 from the ausBΔ strain
providing evidence that the lactone formation is catalyzed by AusB. BLAST analysis
showed that AusB has 54% amino acid sequence similarity to CpdB of Pseudomonas sp.
strain HI-70, which was demonstrated to be a Baeyer-Villiger monooxygenase (BVMO).29
Some conserved motifs are shared between all the members of the BVMO family.30
Analysis of the predicted amino acid sequence of AusB, revealed that it, indeed, has
conserved motifs found in typical BVMO sequences. They are two Rossmann folds (178-
GAGFGG-183 and 374-GTGSTA-379) for binding FAD and NADPH, a BMVO fingerprint
(338-FQGHIFHTARWD-349) and two other conserved motifs (210-GG-211 and 561-
DLVVLATG-568). The underlined sequences are conserved among members of this class
of enzyme. Based on homology, conserved motifs and the accumulation of compound 4 in
the ausB deletant, we deduce that ausB encodes a BVMO that catalyzes the formation of Ɛ-
lactone A ring of austinol/dehydroaustinol. The methyl ester connected to carbon 8' of
protoaustinoid A (4) suggests that a methyltransferase should be involved in the early stage
of the pathway. Since we were unable to isolate the proposed compound 15 and 16 from our
mutant strains, we cannot say whether the esterification step occurs before or after
cyclization by AusL.
The next steps involve the cleavage and rearrangement of the tetraketide portion of the
intermediates from compound 5 to compound 9. Simpson’s group proposed that this
rearrangement involves hydroxylation of the C-5', followed by α-ketol rearrangement and
reduction of the ketone with lactone formation by the attack of the hydroxyl group on the
carboxy group.12 Our results show that these steps of the pathway involve at least four genes
ausJ, ausK, ausH, ausI. The ausJ deletant accumulated compound 5 (Fig. 5B), suggesting
that this enzyme is responsible for the acid-catalyzed keto-rearrangement and ring
contraction of the tetraketide portion to generate compound 6. The ausK deletant produced
three compounds 6, 10, and 11. We propose that compounds 10 and 11 are shunt products of
the pathway. BLAST analysis showed that AusK has 66% amino acid similarity to Nor1
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which converts the 1′ keto group of norsolorinic acid to the 1’ hydroxyl group of averantin
in A. parasiticus.31 We speculate that this enzyme is responsible for reducing the C-5′ keto
of compound 6 to hydroxyl, and this hydroxyl oxygen then attacks the carboxyl to form the
γ-lactone ring in the triketide portion of the molecule. A similar mechanism has been
proposed in Simpson’s labeling study.12
1D and 2D NMR revealed that compounds 6 and 10 are constitutional isomers. Acetyl and
hydroxyl groups are at C-6′ in compound 6 and at C-4′ in compound 10. (Please see
supplemental information for details.) The presence of two isomers indicates to us that the
keto rearrangement doesn’t occur in a stereoselective manner. The alkyl shift can be from
C-5′ to either C-4′ or C-6′ to form compound 10 and 6 respectively. 11 was also found in
this deletant and might be a shunt product made by oxidizing C-5′ of compound 10 to
carboxylic acid followed by beta-keto-acid decarboxylation oxidation by other endogenous
enzymes. Since we didn’t detect conversion of compound 6 to any compound similar to 11,
the enzymes may prefer only compound 10 as substrate rather than compound 6. Among all
the deletants, compound 10 was only found in the ausK deletion strain. Thus the
consumption of compound 6 by AusK and the enzymes downstream in the pathway may
lead the reaction to go through the major route of the pathway instead of the shunt path.
When we analyzed the metabolites of ausH deletants, we found an accumulation of
compound 12 (5′ R configuration), which proved to be a stereoisomer of 7 (5′ S
configuration) by 1D and 2D NMR and X-ray crystallographic analysis. AusH is annotated
as a hypothetical enzyme on both Broad Institute and CADRE databases. BLAST analysis
showed that none of its homologs have been studied so far. Our study suggests that AusH
may play a role in altering AusK’s stereospecificity for its product. When there is no AusH
present, AusK produces the 5′ R γ-hydroxyl ester precursor of compound 12. When AusH
is present, AusK produces the 5′ S γ-hydroxyl ester precursor of compound 7. Therefore,
AusH could function as an accessory enzyme working in tandem with AusK, to make
compound 7.
BLAST analysis revealed that AusI has 52% similarity to SmP450-2, a P450
monooxygenase, which mediates the lactone formation of GA9 in gibberellin biosynthesis in
Sphaceloma manihoticola.32 The ausI deletant produces isoaustinone (7). The accumulation
of this compound suggests that ausI encodes a Baeyer-Villiger monooxygenase (BVMO)
which inserts an oxygen atom between the C-4’ and vicinal carbon at C-3’ to create a
lactone ring. Another intermediate, compound 8, was isolated along with compound 7 from
this gene deletant strain. Compound 8 has an additional hydroxyl on C-11 to compound 7. It
is possible that this modification is performed by a downstream enzyme AusG encoded by
AN9248.4 which we propose to be a hydroxylase. AusG has 59% similarity to SmP450-1, a
P450 monooxygenase, that mediates four oxidation steps in gibberellin biosynthesis in
Sphaceloma manihoticola.32 Austinolide (9) was isolated from our ausG deletant strain. This
suggests ausG encodes a hydroxylase that catalyzes C-11 hydroxylation to form austinol.
Finally, we have been unable to locate a gene that we can show is responsible for converting
austinol to dehydroaustinol. It is possible that additional genes involved in the pathway have
yet to be identified or the conversion is spontaneous and not enzyme catalyzed.
Interestingly, although the LC/MS profile of AN11217.4 mutant suggests that this gene is
not required for meroterpenoid biosynthesis, we found that the metabolite profile of this
mutant is different from other meroterpenoid producing mutants and LO2026 (control
strain). In LO2026, the amount of austinol is greater than dehydroaustinol, but the amount of
austinol and dehydroaustinol are about the same in the AN11217.4 mutant (Fig. 3A and 5B).
BLAST analysis showed that this gene has 45% identity to Bcmfs1 from Botryotinia
fuckeliana (Table S11). Bcmfs1 is an efflux pump, which belongs to major facilitator
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superfamily (MFS). This enzyme can protect B. fuckeliana against natural toxins and
fungicides by secreting them out.33
Several MFS coding genes have been found in natural product gene clusters and are
responsible for transporting specifically these metabolites out of producer organisms34 such
as TOXA in the HC toxin pathway of C. carbonum,35 TRI12 in trichothecene biosynthesis
of F. sporotrichioides36 and CFP in the cercosporin pathway of C. kikuchii.37 Loss of TRI12
and CFP leads to the reduction in toxin production, suggesting that feedback inhibition may
turn off the pathway genes when the toxic level is too high to be tolerated by these
organisms.34,36,37
The MFS encoded by AN11217.4 could, therefore, be involved in the transportation of
austinol/dehydroaustionl pathway metabolites. One, admittedly speculative, possibility is
that the lower level of austinol in the mutant is due to the toxicity of austinol to its producer
organism, A. nidulans. In addition, accumulation of austinol in the cell might allow more
austinol to be converted to dehydroaustinol. Both effects may lead to the observed
difference in metabolite profile of AN11217.4 deletion strains relative to the parental strain.
However, whether the austinol is toxic to A. nidulans is still unknown and although it has
been seen in many cases that pathway specific efflux is responsible for secreting pathway
metabolites out of the host, there are exceptions. For example, AflT, a putative MFS
transporter in the aflatoxin gene cluster in A. parasiticus does not play a significant role in
aflatoxin secretion.34 In addition, it has been shown that some non-pathway specific
transporters in some cases can compensate for the function of an MFS.34 The role of the
product of AN11217.4 in austinol/dehydroaustinol secretion is, thus, by no means certain
and awaits further investigation.
Regarding the organization of the austinol/dehydroaustinol biosynthetic pathway genes in A.
nidulans, one of the most interesting aspects of these genes is that they are located in two
separate gene clusters. In fungi, the genes that encode the proteins of a particular secondary
metabolite biosynthetic pathway are generally clustered together as is the case in
prokaryotes.1,38 Although secondary metabolite genes in plants are not known to be
clustered, there is growing evidence that in certain systems they are indeed clustered.38
There is strong evidence for horizontal transfer of a secondary metabolite gene cluster from
Aspergillus to Penicillium39 and it has been suggested that clusters of secondary metabolite
biosynthetic genes might confer selective advantages to themselves with evolution favoring
their propagation and survival as a unit.40 There is some precedence, however, for split gene
clusters in fungi. The genes for T-toxin biosynthesis in Cochliobolus heterostrophus are in
two unlinked loci41 and the genes for prenylated xanthone biosynthesis in A. nidulans are in
three separate regions of the genome.14 It is worth noting, moreover, that without the
sequenced genome and efficient gene targeting techniques, it would not have been possible
to elucidate the austinol/dehydroaustionol clusters. It is possible that split or fragmented
clusters are more common in fungi than has been thought and that they are being discovered
now because tools have been developed that facilitate their discovery.
We wondered if the two austinol/dehydroaustinol clusters might be functionally specialized
(e.g. the early steps of the pathway might require products of genes in cluster A and late
steps require products in cluster B). As Figure 6 demonstrates, however, this is not the case.
In cluster B (the prenyltransferase cluster) there is a sequence between AN11205.4 and
AN9256.4 (nucleotides 76655 to 77031 on linkage group VIII) that does not appear to be
part of a functional gene but has strong nucleotide identity with a portion of AN8383.4 (in
SAT domain of AN8383.4) (P = 6.7e-44). We speculate that the two clusters were once part
of a single contiguous cluster that has been split by chromosomal rearrangement involving a
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partial duplication of AN8383.4 and translocation of AN8383.4, AN8379.4, AN8380.4,
AN8381.4, AN8382.4 and AN8384.4, leaving only a dysfunctional remnant of AN8383.4
behind in the prenyltransferase cluster. If this speculation is correct, it follows that the
translocation did not disrupt the co-regulation of the genes of the separated gene clusters.
We searched for synteny with secondary metabolite clusters in other species of Aspergillus
to determine if any of these species might have an ancestral cluster syntenic with clusters A
and B. We found a gene cluster in A. terreus extending from ATEG10077.1 to
ATEG10085.1 (http://www.broadinstitute.org/) that exhibits substantial synteny with
clusters A and B. (Fig. S21). It is highly speculative but possible that the putative
meroterpenoid cluster in A. terreus shares a common ancestor with the meroterpenoid
clusters A and B in A. nidulans. The product of the A. terreus cluster is currently unreported
although A. terreus is known to produce the meroterpenoids, terretonin and territrem.3,4
Another interesting aspect of the two A. nidulans clusters is that there are a total of eight
annotated genes internal to the clusters that are not required for austinol or dehydroaustionol
biosynthesis. While it is possible that some of them are not actual genes and are simply
missanotated sequences, others are clearly real and some of them are, on the basis of
homology, predicted to have a role in secondary metabolism (Table S11). While we can
only speculate as to the functions of these genes, it is worth noting that in A. nidulans the
genes required for monodictyphenone synthesis are a subset of the prenyl xanthone
biosynthetic pathway and that one gene, mdpE, is required for monodictyphenone
biosynthesis but not prenyl xanthone biosynthesis and a second gene, mdpD, is required for
prenyl xanthone biosynthesis but not monodictyphenone biosynthesis.14 This raises the
highly speculative but intriguing possibility that fungi may use differential regulation of
genes within secondary metabolite gene clusters to multiply the number of secondary
metabolites produced by the clusters.
CONCLUSION
Pioneering work primarily using isotopic precursors in the 80's enabled the Simpson group
to propose biosynthetic mechanisms for meroterpenoids involving the C-alkylation of 3,5-
dimethylorsellinic acid.12 The alkylated intermediate is epoxylated and cyclized to form a
tetracyclic intermediate, which then undergoes drastic modifications to form austinol and
dehydroaustinol. Targeted gene deletion studies of genes flanking the genes encoding the
NR-PKS on chromosome V and the prenyltransferase on chromosome VIII allowed the
isolation of several stable intermediates in amount sufficient for full NMR characterization.
Many of the intermediates isolated share structural similarities to the proposed structures
from the earlier labeling work and also intermediates isolated from wild type strain of
Penicillium sp. LaBioMi-02423 and provide direct support for the pathway proposed by the
Simpson group.
In summary we have shown that genes from two different gene clusters on two different
chromosomes are required to make for dehydroaustinol and austinol in A. nidulans. One
cluster contains the PKS gene and the other cluster contains the prenyltransferase gene. By
creating a series of deletants and analyzing the metabolite profiles using LC/MS, fourteen
genes were identified to be involved in austinol/dehydroaustinol biosynthesis. Based on the
intermediates and bioinformatics study, we have proposed a biosynthetic pathway for
austinol/dehydroaustinol.
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Strains and molecular genetic manipulations
A. nidulans strains used in this study are listed in Table S1 in the supplemental material. All
the deletant strains were generated by replacing each gene with the Aspergillus fumigatus
pyrG gene in the A. nidulans strain LO2026. The construction of fusion PCR products,
protoplast production, and transformation were carried out as described previously.19 For
the construction of the fusion PCR fragments, two 1,000-bp fragments of genomic A.
nidulans DNA, upstream and downstream of the targeted gene, were amplified by PCR.
Primers used in this study are listed in Table S2 in the supplemental material. Fusion PCR
was set up with the two amplified flanking sequences and the A. fumigatus pyrG selectable
marker cassette as the template DNA. The three fragments were fused into a single molecule
and amplified with two nested primers. Diagnostic PCR analyses of the deletion mutants and
their parent strain, LO2026, were performed with the external primers used in the first round
of PCR. The difference in the size between the gene replaced by the selective marker and the
native gene allowed the determination of correct gene replacement. In addition, the
correctness of the gene replacements was further confirmed using external primers along
with primers located inside the marker gene. Diagnostic PCR with multiple primer sets
allowed us to determine reliably if correct gene targeting had occurred. Although this
technique does not allow us to determine if additional heterologous integrations have
occurred, extra insertions rarely happen (<2%) with the strains used.19 At least two
transformants per gene were selected and their metabolite profiles were examined. The
probability that two random extra insertions would occur and would give the same altered
metabolite profile is vanishingly small.
Fermentation and LC/MS analysis
The A. nidulans control strain LO2026 and deletion strains were cultivated at 37°C on solid
YAG (complete medium; 5 g of yeast extract/liter, 15 g of agar/liter, and 20 g of D-glucose/
liter supplemented with 1.0-ml/liter of a trace element solution and required supplements) at
1 × 107 spores per 10 cm diameter plate (with 18 ml of medium per plate). After 3 days,
agar was chopped into small pieces and the material was extracted with 50 ml of methanol
(MeOH) followed by 50 ml of 1:1 CH2Cl2-MeOH, each with 1 h of sonication. The extract
was evaporated in vacuo to yield a residue, which was suspended in H2O (25 ml), and this
suspension was then partitioned with ethyl acetate (EtOAc) twice. The combined EtOAc
layer was evaporated in vacuo, redissolved in 1ml DMSO, and then diluted with 4 volumes
of MeOH. 4ul of this dilute crude extract was injected for high-performance liquid
chromatography (HPLC)-photodiode array detection-mass spectrometry (MS) analysis.
Liquid chromatography-MS (LC-MS) was carried out using a ThermoFinnigan LCQ
advantage ion trap mass spectrometer with a reverse-phase C18 column (2.1 by 100 mm
with a 3 µm particle size; Alltech Prevail) at a flow rate of 125 µl/min. The solvent gradient
for HPLC was 95% acetonitrile (MeCN)-H2O (solvent B) in 5% MeCN-H2O (solvent A),
both containing 0.05% formic acid, as follows: 0% solvent B from 0 to 5 min, 0 to 100%
solvent B from 5 to 35 min, 100% solvent B from 35 to 40 min, 100 to 0% solvent B from
40 to 45 min, and reequilibration with 0% solvent B from 45 to 50 min. The positive mode
was used for the detection of austinol/dehydroaustinol and their intermediates. Negative ion
electrospray ionization (ESI) was used for the detection of compound 3. Conditions for MS
included a capillary voltage of 5.0 kV, a sheath gas flow rate at 60 arbitrary units, an
auxiliary gas flow rate at 10 arbitrary units, and an ion transfer capillary temperature of
350°C.
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Isolation, identification of secondary metabolites and compound spectral data
For structure elucidation, each A. nidulans deletant was cultivated at 37 °C on 30 YAG
plates at 2.25 × 107 spores per 15-cm plate (~55 ml of medium per plate). The desired
intermediates from crude extracts of each deletant strain were isolated with flash
chromatography and reverse phase HPLC. (Please see supplemental information for details).
Melting points were determined with a Yanagimoto micromelting point apparatus and are
uncorrected. IR spectra were recorded on a GlobalWorks Cary 14 Spectrophotometer.
Optical rotations were measured on a JASCO P-200 digital polarimeter. NMR spectra were
collected on a Varian Mercury Plus 400 spectrometer. High-resolution mass spectrometry
was performed on Agilent 6210 time of flight LC–MS. The X-ray crystallographic data were
collected using Bruker KAPPA APEX II diffractometer in the X-ray crystallography
laboratory of the California Institute of Technology.
3,5-Dimethylorsellinic acid
Yellowish white solid, mp 182 – 185 °C; IRmaxZnSe 3448, 1685, 1208, 1142 cm−1; For UV-
Vis and ESIMS spectra, see Figure S1; 1H NMR (acetone-d6, 400 MHz) 2.10 (3H, s), 2.14
(3H, s), 2.50 (3H, s); 13C NMR (acetone-d6, 100 MHz) 8.8 (q), 12.4 (q), 19.0 (q), 106.2 (s),
108.9 (s), 116.4 (s), 138.6 (s), 159.0 (s), 161.6 (s), 175.3 (s). 1H and 13C NMR data were in
good agreement with the published data.42
Protoaustinoid A
Yellowish gum; For UV-Vis and ESIMS spectra, see Figure S1; For 1H and 13C NMR data,
see Table S3.
Preaustinoid A3
Colorless solid, mp 209 – 212 °C; [α]D24 +250.4° (CHCl3, c 0.9); IRmaxZnSe 3371, 1733,
1707, 1646, 1374, 1297, 1230, 1110, 1004, 923 cm−1; For UV-Vis and ESIMS spectra, see
Figure S1; For 1H and 13C NMR data, see Table S9 and S10. 1H and 13C NMR data were in
good agreement with the published data.23
Preaustinoid A4
Colorless needles, mp 167–171 °C; [α]D24 +469.5° (CHCl3, c 1.7); IRmaxZnSe 3383, 1759,
1715, 1654, 1376, 1282, 1239, 1156, 1109, 984, 911 cm−1; For UV-Vis and ESIMS spectra,
see Figure S1; For 1H and 13C NMR data, see Table S4; HRESIMS, [M + H]+ m/z found
457.2227; calc. for C26H32O7: 457.2221.
Isoaustinone
Colorless solid, mp >300 °C; [α]D24 +462.6° (CHCl3, c 0.3); IRmaxZnSe 3490, 1752, 1708,
1375, 1285, 1236, 1159, 1114, 1083, 1053, 981, 925 cm−1; For UV-Vis and ESIMS spectra,
see Figure S1; For 1H and 13C NMR data, see Table S9 and S10. 1H and 13C NMR data
were in good agreement with the published data.23
11 β-Hydroxyisoaustinone
Colorless needles, mp 225 – 229 °C; [α]D24 +292.2° (CHCl3, c 0.1); IRmaxZnSe 3490, 3378,
1764, 1750, 1691, 1312, 1241, 1177, 1118, 1086, 1037, 983, 927 cm−1; For UV-Vis and
ESIMS spectra, see Figure S1; For 1H and 13C NMR data, see Table S5; HRESIMS, [M +
H]+ m/z found 443.2069; calc. for C25H30O7: 443.2064.
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Colorless needles, mp 259 – 263 °C; [α]D24 +436.3° (CHCl3, c 1.0); IR nmaxZnSe 3458,
1780, 1717, 1375, 1293, 1218, 1179, 1117, 1075, 979, 910 cm−1; For UV-Vis and ESIMS
spectra, see Figure S1; For 1H and 13C NMR data, see Table S9 and S10. 1H and 13C NMR
data were in good agreement with the published data.23
Preaustinoid A5
Colorless amorphous solid, mp unmeasurable; [α]D24 +162.0° (CHCl3, c 0.6); IRmaxZnSe
3426, 1760, 1715, 1374, 1265, 1235, 1110, 1048, 973, 908 cm−1; For UV-Vis and ESIMS
spectra, see Figure S1; For 1H and 13C NMR data, see Table S6; HRESIMS, [M + H]+ m/z
found 457.2228; calc. for C26H32O7: 457.2221.
Austinoneol A
Colorless needles, mp 219 – 224 °C; [α]D24 +366.8° (CHCl3, c 0.9); IRmaxZnSe 3403, 1755,
1721, 1711, 1661, 1393, 1375, 1278, 1223, 1112, 1060, 974, 906 cm−1; For UV-Vis and
ESIMS spectra, see Figure S1; For 1H and 13C NMR data, see Table S9 and S10. 1H
and 13C NMR data were in good agreement with the published data.43
(5'R)-Isoaustinone
Colorless plates, mp 234–237 °C; [α]D24 +428.7° (CHCl3, c 0.3); IRmaxZnSe 3382, 1755,
1712, 1375, 1285, 1201, 1113, 1066, 1003, 915 cm−1; ; For UV-Vis and ESIMS spectra, see
Figure S1; For 1H and 13C NMR data, see Table S7; HRESIMS, [M + H]+ m/z found
427.2120; calc. for C25H30O6: 427.2115.
Neoaustinone
Yellowish gum; [α]D24 +357.1° (CHCl3, c 0.2); IRmaxZnSe 3373, 1760, 1711, 1657, 1380,
1312, 1196, 1112, 1071, 1017, 979 cm−1; For UV-Vis and ESIMS spectra, see Figure S1;
For 1H and 13C NMR data, see Table S8; HRESIMS, [M + H]+ m/z found 443.2070; calc.
for C25H30O6: 443.2064.
X-ray Crystallographic Analysis of (5'R)-Isoaustinone
A colorless crystal of 12 with dimensions 1.21 × 0.21 × 0.19 mm3 was selected for X-ray
analysis. Structure analysis was performed using SHELXS-97 program. The compound
crystallized in the monoclinic space group I2, with a = 16.9929(9) Å, b = 7.3879(4) Å, c =
17.1390(9) Å, = 95.180(3)°, volume = 2142.9(2) Å3, Z = 4, ρcalc = 1.322 Mg/m3, λ =
0.71073 Å. Intensity data were collected on a Bruker instrument with an APEX II detector
and crystals were mounted on a glass fiber using Paratone oil then placed on the
diffractometer under a nitrogen stream at 100K. A total of 30291 data points were collected
in the range 2.39° ≤ θ ≤ 31.83°, yielded 7321 unique reflections. Crystallographic data have
been deposited at the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be
obtained on request, free of charge, by quoting the publication citation and the deposition
number 773039.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Meroterpenoids from Aspergillus species.
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Intermediates isolated from gene deletion mutants.
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HPLC profile of extracts from (A) LO2026 (background control strain), (B) AN8383.4Δ
PKS deletant (C) AN9259.4Δ prenyltransferase deletant and (D) AN8142.4Δ as detected by
UV at 254 nm and mass spectrometry. Austinol 1 [M+H]+ m/z = 459 and dehydroaustinol 2
[M+H]+ m/z = 457 are detected using positive ion mode and 3,5-dimethylorsellinic acid 3
[M-H]− m/z = 195 is detected using negative ion mode. EIC = Extracted Ion Chromatogram.
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(A) Organization of the polyketide synthase gene cluster (cluster A) for austinol/
dehydroaustinol biosynthesis in A. nidulans. Each arrow indicates relative size and the
direction of transcription of the ORFs deduced from analysis of nucleotide sequences. On
the basis of our gene deletion results, genes in black are involved in austinol/
dehydroaustinol biosynthesis while those in white are not. (B) HPLC profile of extracts of
strains in the cluster as detected by UV absorption at 254 nm. Numbering on peaks
corresponds to the intermediates shown in Figure 2.
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(A) Organization of the prenyltransferase gene cluster (cluster B) for austinol/
dehydroaustinol biosynthesis in A. nidulans. Each arrow indicates the relative size and the
direction of transcription of the ORFs deduced from analysis of nucleotide sequences. On
the basis of our gene deletion results, genes in black are involved in austinol/
dehydroaustinol biosynthesis while those in white are not. (B) HPLC profile of extracts of
strains in the cluster as detected by UV absorption at 254 nm. Numbering on peaks
corresponds to the intermediates shown in Figure 2.
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Proposed biosynthesis pathway of austinol/dehydroaustinol. The clusters in which the genes
are found (Cluster A or Cluster B) are indicated.
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Table 1
The genes required for austinol/dehydroaustinol biosynthesis in A. nidulans
ORFs Homologs
Gene Predicted size (aa) Match from BLAST search at NCBI (accession no.) Identity/s imilarity (%)
AN8379.4 (ausB) 745 cyclopentadecanone 1,2-monooxygenase [Pseudomonas sp. HI-70]
(BAE93346)
37/54
AN8381.4 (ausC) 638 cyclododecanone monooxygenase [Rhodococcus ruber] (AAL14233) 43/56
AN8383.4 (ausA) 2476 methylorcinaldehyde synthase [Acremonium strictum] (CAN87161) 32/51
AN8384.4 (ausD) 282 Hypothetical protein
AN9246.4 (ausE) 298 Fumonisin C-5 hydroxylase Fum3p [Gibberella moniliformis]
(AAG27131)
34/52
AN9247.4 (ausF) 177 Hypothetical protein
AN9248.4 (ausG) 529 P450 monooxygenase [Sphaceloma manihoticola] (CAP07651) 40/59
AN9249.4 (ausH) 174 Hypothetical protein
AN9253.4 (ausI) 501 P450 monooxygenase [Sphaceloma manihoticola] (CAP07653) 32/55
AN11214.4 (ausJ) 162 Hypothetical protein
AN11205.4 (ausK) 398 Norsolorinic acid reductase [Aspergillus parasiticus] (Q00258) 48/66
AN9257.4 (ausL) 204 Terpene cyclases pyr4 [Aspergillus fumigatus F37]13 32/55
AN11206.4 (ausM) 479 a. PaxM [Penicillium paxilli] (AAK11530)




AN9259.4 (ausN) 330 a. 4-hydroxybenzoate geranyltransferase [Lithospermum
erythrorhizon] (BAB84122)
b. Prenyltransferase pyr6 [Aspergillus fumigatus F37]13
a. 30/49
b. 30/46
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